Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2678 |  AURA Aura Biosciences, Inc. - Common Stock | 7.06 USD | +0.43% | +4.28% | +6.97% | +11.36% | 729.91 M USD | ||
| 2698 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 2.05 USD | -4.65% | -5.09% | +9.04% | +69.42% | 707.57 M USD | ||
| 2702 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 35.70 USD | -2.30% | +8.05% | +21.39% | +108.16% | 673.63 M USD | ||
| 2706 |  CRMD CorMedix Inc. - Common Stock | 8.79 USD | -0.90% | +4.52% | +2.09% | -22.21% | 689.59 M USD | ||
| 2707 |  CADL Candel Therapeutics, Inc. - Common Stock | 9.55 USD | -3.05% | -9.82% | +11.70% | +78.84% | 699.73 M USD | ||
| 2716 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 12.44 USD | -2.96% | -4.75% | +40.25% | +10.09% | 650.32 M USD | ||
| 2729 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 6.40 USD | -0.16% | -1.84% | +9.59% | +949.18% | 671.30 M USD | ||
| 2739 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.70 USD | -4.42% | +2.92% | +10.74% | -18.89% | 650.09 M USD | ||
| 2773 |  MDXG MiMedx Group, Inc - Common Stock | 4.20 USD | 0.00% | +9.09% | +13.21% | -40.43% | 625.57 M USD | ||
| 2775 |  ACHV Achieve Life Sciences, Inc. - Common Shares | 6.08 USD | -6.75% | -10.72% | +8.77% | +173.87% | 624.17 M USD | ||
| 2783 |  MNPR Monopar Therapeutics Inc. - Common Stock | 92.54 USD | -2.81% | -5.30% | +56.05% | +69.43% | 619.93 M USD | ||
| 2784 |  KYTX Kyverna Therapeutics, Inc. - Common Stock | 9.56 USD | -1.24% | +12.74% | +22.25% | +237.81% | 581.20 M USD | ||
| 2789 |  NGNE Neurogene Inc. - Common Stock | 36.32 USD | -1.30% | +12.38% | +25.59% | +23.45% | 573.93 M USD | ||
| 2814 |  IMMX Immix Biopharma, Inc. - Common Stock | 10.91 USD | -9.23% | +12.01% | +36.20% | +307.09% | 593.63 M USD | ||
| 2825 |  ALT Altimmune, Inc. - Common Stock | 3.01 USD | -0.33% | -9.06% | +8.66% | -34.42% | 585.37 M USD | ||
| 2842 |  PROK ProKidney Corp. - Class A Ordinary Shares | 1.89 USD | -3.08% | -1.05% | +10.53% | -9.13% | 570.89 M USD | ||
| 2843 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 8.79 USD | -5.79% | -17.70% | +8.12% | -1.01% | 547.83 M USD | ||
| 2855 |  ARVN Arvinas, Inc. - Common Stock | 8.46 USD | -1.51% | +3.42% | +17.17% | -9.03% | 545.85 M USD | ||
| 2858 |  XOMA XOMA Royalty Corporation - Common Stock | 44.31 USD | +0.96% | +4.01% | +4.93% | +25.70% | 555.69 M USD | ||
| 2876 |  STTK Shattuck Labs, Inc. - Common Stock | 6.99 USD | -3.72% | +3.86% | +71.32% | +742.17% | 536.00 M USD |
Noticias Biotechnology Stocks
BofA reitera su calificación de Beam Therapeutics tras fallo arbitral
¿Por qué cae hoy la acción de Beam Therapeutics?
¿Por qué las acciones de Prime Medicine se disparan hoy?
La acción de Incyte alcanza un máximo de 52 semanas en 118,77 dólares
Las acciones de Prime Medicine suben tras ganar arbitraje contra Beam
Resultados de Nurix Therapeutics: la atención se centra en el acuerdo con Roche
Las acciones de Edgewise Therapeutics alcanzan máximos históricos a 43,96 dólares
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
 PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
 VANI Vivani Medical, Inc. - Common Stock | 1.50 | +11.11% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 CCCC C4 Therapeutics, Inc. - Common Stock | 3.81 | -12.41% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |